We report the molecular docking analysis for oral cancer drug, Imiquimod with TGF-β signaling pathway targets such as Smad2, GATA2, and MAFG which are mainly plays a crucial role in regulation of Epithelial Mesenchymal Transition(EMT) in cancer cells. This evidence concerns the gene GATA2 and lip and oral cavity carcinoma.